Diabetic nephropathy (DN) is a major healthcare challenge. It occurs in up to 50% of those
living with diabetes, is a major cause of end‐stage kidney disease (ESKD) that requires …

The International Diabetes Federation predicts that the number of people with diabetes in
the world will rise from 194 million today to 333 million in 2025 [1]. The next 25–50 years will …

OBJECTIVES This study aimed to identify clinical features associated with premature
mortality in a large contemporary cohort of adults with type 1 diabetes. RESEARCH DESIGN …

The long-term vascular complications of diabetes include retinopathy, nephropathy,
neuropathy, and macrovascular disease. The outcomes are:• visual impairment and …

This article is a chapter in the ISPAD Clinical Practice Consensus Guidelines 2009
Compendium. The complete set of guidelines can be found at www. ispad. org. The …

Diabetic nephropathy (DN) is the leading cause of end stage renal disease (ESRD).
Although the pathogenesis of DN is multifactorial, local inflammatory stress may result from …

Objective To examine short and long term time trends in mortality among patients with early
onset (age 0-14 years) and late onset (15-29 years) type 1 diabetes and causes of deaths …

Historically, patients with type 1 diabetes and macroalbuminuria had high competing risks:
cardiovascular death or renal failure. Here, we assessed these risks in patients receiving …

OBJECTIVE A common belief is that only a minority of patients with type 1 diabetes (T1D)
develop advanced kidney disease and that incidence is higher among men and lower in …

OBJECTIVE—Cardiac autonomic neuropathy (CAN) has been associated with a poor
prognosis in patients with diabetes. Because CAN is common in patients with diabetic …